Not finding it? Sign in to also search OpenAlex live.
-
MRI-Based Radiomics Analysis for the Pretreatment Prediction of Pathologic Complete Tumor Response to Neoadjuvant Systemic Therapy in Breast Cancer Patients: A Multicenter Study
Renée W. Y. Granzier, Abdalla Ibrahim, Sergey P. Primakov, Sanaz Samiei, Thiemo J. A. van Nijnatten, Maaike de Boer, +7 more
42citations -
A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial2020 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Thomas Karn, Tobias Meißner, Karsten Ernst Weber, Christine Solbach, Carsten Denkert, Knut Engels, +19 more
16citations -
Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial2023 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Peter Andreas Fasching, Christopher W. Szeto, Carsten Denkert, Stephen Charles Benz, Karsten Ernst Weber, Patricia Spilman, +18 more
8citations -
BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer2023 Breast Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Marte C. Liefaard, Anna van der Voort, Mette S. van Ramshorst, Joyce Sanders, Shiva Vonk, Hugo M. Horlings, +10 more
6citations -
Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer2021 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Bruno Valentin Sinn, Sibylle Loibl, Claus Alexander Hanusch, Dirk-Michael Zahm, Hans‐Peter Sinn, Michael Untch, +16 more
46citations -
An Analysis of PIK3CA Hotspot Mutations and Response to Neoadjuvant Therapy in Patients with Breast Cancer from Four Prospective Clinical Trials2024 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Paul Jank, Thomas Karn, Marion van Mackelenbergh, Judith Lindner, Denise Treue, Jens Huober, +18 more
13citations -
Value of Breast and Axillary Tumor-Infiltrating Lymphocytes for Response to Neoadjuvant Chemo-(Immuno)Therapy in Clinically Node-Positive Breast Cancer2026 Clinical Breast Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Melissa Lenaerts, Loes F. S. Kooreman, Florien J G van Amstel, P. J. van Diest, Sander M. J. van Kuijk, Ernest J. T. Luiten, +28 more
0citations -
Baseline CD4+ and expansion of γδ T cells correlate with response to durvalumab in triple‐negative breast cancer patients2024 Clinical and Translational Medicine article Medicine Cancer Immunotherapy and Biomarkers Open access
Chiara Massa, Thomas Karn, Karsten Ernst Weber, Andreas Schneeweiß, Claus Alexander Hanusch, Jens‐Uwe Blohmer, +16 more
2citations -
AI-assisted iTIL scoring in melanoma lymph node metastases associates with neoadjuvant immunotherapy response2026 npj Precision Oncology article Medicine Cutaneous Melanoma Detection and Management Open access
Lindsay V.M. Leek, Vanessa Botha, Marcos Da Silva Guimaraes, Joyce Sanders, Petros Dimitriadis, Siamak Hajizadeh, +13 more
0citations -
Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer2021 Breast Cancer Research and Treatment article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Emma Josephine Groen, Marieke E. M. van der Noordaa, Michael Schaapveld, Gabe S. Sonke, Ritse M. Mann, Mette S. van Ramshorst, +4 more
17citations -
Impact of personalized response-directed surgery and adjuvant therapy on survival after neoadjuvant immunotherapy in stage III melanoma: Comparison of 3-year data from PRADO and OpACIN-neo2024 European Journal of Cancer article Medicine Cutaneous Melanoma Detection and Management Open access
Irene L. M. Reijers, Alexander Maxwell Menzies, Marta López‐Yurda, Judith M. Versluis, Elisa A. Rozeman, Robyn P.M. Saw, +18 more
33citations -
Papillary renal cell carcinoma – exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review
Marit Ahrens, John B.A.G. Haanen, Laurence K. Albiges, Marine Gross‐Goupil, Ekaterini Boleti, Gwénaëlle Gravis, +29 more
1citations -
Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapy⋆2021 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics Open access
Carsten Denkert, Michael Untch, Stephen Charles Benz, Andreas Schneeweiß, Karsten Ernst Weber, Sabine Schmatloch, +22 more
23citations -
AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with response
Mark Schuiveling, Isabella A.J. van Duin, Laurens S. ter Maat, Rik Jasper Verheijden, Franchette W.P.J. van den Berkmortel, Gerben Eise Breimer, +14 more
2citations -
791MO Clinical and tumor characteristics of patients (pts) with recurrence after pathologic response upon neoadjuvant ipilimumab (IPI) + nivolumab (NIVO) in stage III melanoma
J.M. Versluis, Robert Elens, Irene L. M. Reijers, Alexander Maxwell Menzies, Astrid A.M. van der Veldt, E. Kapiteijn, +12 more
0citations -
Decreased integrity of the monoaminergic tract is associated with a positive response to MPH in patients with vascular cognitive impairment - proof of principle study STREAM-VCI2022 Cerebral Circulation - Cognition and Behavior article Medicine Dementia and Cognitive Impairment Research Open access
Jolene F Leijenaar, Silvia Ingala, Carole H. Sudre, Henk J. M. M. Mutsaerts, Anna Elisabeth Leeuwis, Wiesje M. van der Flier, +6 more
0citations -
Is PET Radiomics Useful to Predict Pathologic Tumor Response and Prognosis in Locally Advanced Cervical Cancer?2024 Journal of Nuclear Medicine article Medicine Radiomics and Machine Learning in Medical Imaging Open access
Angela Collarino, Vanessa Feudo, Tina Pasciuto, Anita Florit, Elisabeth A. G. Pfaehler, Marco De Summa, +11 more
19citations -
Histopathological response to chemotherapy and survival of mucinous type gastric cancer2024 JNCI Journal of the National Cancer Institute article Medicine Gastric Cancer Management and Outcomes Open access
Irene A. Caspers, Astrid E. Slagter, Pauline A. J. Vissers, Martha Lopez-Yurda, Laurens Victor Beerepoot, Jelle P. Ruurda, +11 more
5citations -
The Effects of Repetitive Use and Pathological Remodeling on Channelrhodopsin Function in Cardiomyocytes2021 Frontiers in Physiology article Neuroscience Photoreceptor and optogenetics research Open access
Balázs Ördög, Alexander S Teplenin, Tim De Coster, Cindy I. Bart, Sven O. Dekker, Juan Zhang, +3 more
9citations -
Baseline and early digital [18F]FDG PET/CT and multiparametric MRI contain promising features to predict response to neoadjuvant therapy in locally advanced rectal cancer patients: a pilot study
Floris A. Vuijk, Shirin Feshtali Shahbazi, Wyanne A. Noortman, Floris H. P. van Velden, Petra Dibbets‐Schneider, Andreas W. K. S. Marinelli, +13 more
4citations